{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:49:41Z","timestamp":1790480981405,"version":"4.1.0"},"reference-count":23,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,6,1]]},"DOI":"10.1210\/jcem.82.6.4000","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:01:43Z","timestamp":1389200503000},"page":"1757-1760","source":"Crossref","is-referenced-by-count":1,"title":["Increased Serum Concentration of Soluble CD30 in Patients with Graves\u2019 Disease and Hashimoto\u2019s Thyroiditis1"],"prefix":"10.1210","volume":"82","author":[{"given":"Motoshi","family":"Okumura","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Osaka University Medical School, 2\u20132 Yamadaoka, Suita, Osaka 565, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh","family":"Hidaka","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Osaka University Medical School, 2\u20132 Yamadaoka, Suita, Osaka 565, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Osaka University Medical School, 2\u20132 Yamadaoka, Suita, Osaka 565, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Takeoka","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Osaka University Medical School, 2\u20132 Yamadaoka, Suita, Osaka 565, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisato","family":"Tada","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Osaka University Medical School, 2\u20132 Yamadaoka, Suita, Osaka 565, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Amino","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Osaka University Medical School, 2\u20132 Yamadaoka, Suita, Osaka 565, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114145690600_R1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The expanding universe of T-cell subsets: Th1, Th2 and more.","volume":"17","author":"Mosmann","year":"1996","journal-title":"Immunol Today"},{"key":"key\n\t\t\t\t2019041114145690600_R2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1210\/edrv-6-2-183","article-title":"Immune mechanisms in Graves\u2019 disease.","volume":"6","author":"Burman","year":"1985","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041114145690600_R3","first-page":"1700","article-title":"Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis.","volume":"77","author":"Chiovato","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114145690600_R4","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1210\/jcem-59-4-734","article-title":"Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto\u2019s thyroiditis but not Graves\u2019 disease.","volume":"59","author":"Bogner","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114145690600_R5","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1210\/jcem-64-4-818","article-title":"Intrathyroidal T cell clones from patients with autoimmune thyroid disease.","volume":"64","author":"MacKenzie","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114145690600_R6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2249.1993.tb08196.x","article-title":"Intrathyroidal lymphocyte subsets, including unusual CD4+ CD8+ cells and CD3loTCR alpha beta lo\/-CD4-CD8- cells, in autoimmune thyroid disease.","volume":"93","author":"Iwatani","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"key\n\t\t\t\t2019041114145690600_R7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0092-8674(92)90180-K","article-title":"Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin\u2019s disease.","volume":"68","author":"Durkop","year":"1992","journal-title":"Cell"},{"key":"key\n\t\t\t\t2019041114145690600_R8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1096\/fasebj.9.1.7821763","article-title":"Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines.","volume":"9","author":"Del Prete","year":"1995","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t2019041114145690600_R9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V85.1.1.bloodjournal8511","article-title":"CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy.","volume":"85","author":"Falini","year":"1995","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019041114145690600_R10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/00002030-199406000-00003","article-title":"High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS.","volume":"8","author":"Pizzolo","year":"1994","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2019041114145690600_R11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1210\/jcem-65-2-324","article-title":"Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves\u2019 disease.","volume":"65","author":"Tamaki","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114145690600_R12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/299065a0","article-title":"Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin\u2019s disease and a subset of normal lymphoid cells.","volume":"299","author":"Schwab","year":"1982","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019041114145690600_R13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4049\/jimmunol.141.2.672","article-title":"Biochemical and structural properties of a Hodgkin\u2019s disease-related membrane protein.","volume":"141","author":"Nawrocki","year":"1988","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t2019041114145690600_R14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/eji.1830190125","article-title":"Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay.","volume":"19","author":"Josimovic-Alasevic","year":"1989","journal-title":"Eur J Immunol"},{"key":"key\n\t\t\t\t2019041114145690600_R15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1200\/JCO.1994.12.4.793","article-title":"Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin\u2019s disease and correlate with clinical features and prognosis.","volume":"12","author":"Nadali","year":"1994","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019041114145690600_R16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2249.1995.tb03851.x","article-title":"High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30+ T cell involvement in the inflamed joints.","volume":"102","author":"Gerli","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"key\n\t\t\t\t2019041114145690600_R17","first-page":"339","article-title":"Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity.","volume":"13","author":"Caligaris-Cappio","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"key\n\t\t\t\t2019041114145690600_R18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI118034","article-title":"Identification of thyroid stimulating hormone receptor-specific T cells in Graves\u2019 disease thyroid using autoantigen-transfected Epstein-Barr virus-transformed B cell lines.","volume":"96","author":"Mullins","year":"1995","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041114145690600_R19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/thy.1996.6.97","article-title":"Different cytokine mRNA profiles in Graves\u2019 disease, Hashimoto\u2019s thyroiditis, and nonautoimmune thyroid disorders determined bu quantitative reverse transcriptase polymerase chain reaction (RT-PCR).","volume":"6","author":"Heuer","year":"1996","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041114145690600_R20","first-page":"1667","article-title":"Recurrence of thyrotoxicosis after attack of allergic rhinitis in patients with Graves\u2019 disease.","volume":"77","author":"Hidaka","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114145690600_R21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/thy.1996.6.349","article-title":"Onset of Graves\u2019 thyrotoxicosis after an attack of allergic rhinitis.","volume":"6","author":"Hidaka","year":"1996","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041114145690600_R22","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1084\/jem.182.6.1655","article-title":"CD30-mediated signaling promotes the development of human T helper type 2-like T cells.","volume":"182","author":"Del Prete","year":"1995","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t2019041114145690600_R23","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/0092-8674(93)90361-S","article-title":"CD30 antigen, a marker for Hodgkin\u2019s lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF.","volume":"73","author":"Smith","year":"1993","journal-title":"Cell"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/82\/6\/1757\/10401656\/jcem1757.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T14:51:00Z","timestamp":1688914260000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/82\/6\/1757\/2656439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,6,1]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1997,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.82.6.4000","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,6,1]]}}}